Sudarshan Pharma Industries Limited (BOM:543828)
India · Delayed Price · Currency is INR 31.90
+0.37 (1.17%)
At close: Nov 6, 2026
BOM:543828 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,118 | 5,834 | 7,350 | 1,784 | 960 | - | |
Market Cap Growth | 17.73% | -20.63% | 312.09% | 85.79% | - | - |
Enterprise Value | 12,026 | 8,003 | 8,573 | 2,007 | 1,312 | - |
Last Close Price | 31.90 | 24.24 | 30.54 | 7.41 | 5.56 | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 26.55 | 25.03 | 49.23 | 15.57 | 13.64 | - |
PS Ratio | 1.04 | 0.83 | 1.46 | 0.39 | 0.21 | - |
PB Ratio | 4.15 | 3.73 | 5.58 | 1.60 | 0.95 | - |
P/TBV Ratio | 4.48 | 4.17 | 5.79 | 1.67 | 0.96 | - |
P/FCF Ratio | - | - | - | 30.22 | - | - |
P/OCF Ratio | - | - | - | 18.41 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.54 | 1.14 | 1.70 | 0.43 | 0.28 | - |
EV/EBITDA Ratio | 17.55 | 15.71 | 21.92 | 8.48 | 8.62 | - |
EV/EBIT Ratio | 18.87 | 16.51 | 22.95 | 8.94 | 9.17 | - |
EV/FCF Ratio | - | - | - | 34.01 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 2.01 | 1.82 | 1.33 | 0.94 | 0.34 | 1.03 |
Debt / EBITDA Ratio | 5.72 | 5.45 | 4.35 | 4.43 | 2.24 | 2.78 |
Debt / FCF Ratio | - | - | - | 17.76 | - | - |
Net Debt / Equity Ratio | 2.00 | 1.82 | 1.31 | 0.92 | 0.22 | 1.02 |
Net Debt / EBITDA Ratio | 5.82 | 5.57 | 4.41 | 4.36 | 1.47 | 2.76 |
Net Debt / FCF Ratio | -3.40 | -3.98 | -3.22 | 17.49 | -0.52 | -5.54 |
Asset Turnover | 1.23 | 1.34 | 1.47 | 1.80 | 2.49 | 3.02 |
Inventory Turnover | 3.11 | 3.45 | 3.89 | 5.27 | 7.10 | 9.47 |
Quick Ratio | 0.60 | 0.52 | 0.60 | 0.82 | 0.79 | 0.72 |
Current Ratio | 1.42 | 1.08 | 1.26 | 1.48 | 1.68 | 1.26 |
Return on Equity (ROE) | 17.21% | 16.23% | 12.26% | 10.77% | 10.76% | 20.06% |
Return on Assets (ROA) | 6.28% | 5.78% | 6.77% | 5.44% | 4.83% | 5.36% |
Return on Invested Capital (ROIC) | 9.16% | 9.97% | 10.75% | 9.98% | 11.56% | 13.43% |
Return on Capital Employed (ROCE) | 18.50% | 26.10% | 25.70% | 18.30% | 12.60% | 29.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.77% | 4.00% | 2.03% | 6.42% | 7.33% | - |
FCF Yield | -14.17% | -12.24% | -7.29% | 3.31% | -44.92% | - |
Dividend Yield | - | - | - | - | 0.75% | - |
Payout Ratio | - | - | - | 6.30% | - | - |
Buyback Yield / Dilution | 1.23% | -0.59% | -1.45% | 0.83% | -66.88% | 5.63% |
Total Shareholder Return | 1.23% | -0.59% | -1.45% | 0.83% | -66.13% | 5.63% |